Teleflex Incorporated

NYSE:TFX

Medical - Instruments & Supplies

Healthcare
$165.85 +0.83%

+$1.04 today

Market cap
$6.58B
Beta
0.82
P/E (TTM)
-5.5
EPS (TTM)
-$22.79
Dividend yield
1.08%
52W Low $100.18High $139.67

Volume 1.16M

Average 0.80M

TFX Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Teleflex IncorporatedNYSE: TFX

Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026

Accumulated OCI remains negative

Q2 FY2026 Accumulated OCI was -$276.98M, compared with -$258.65M a year earlier.

Context

  • Accumulated OCI amounted to 4.1% of total assets at the end of Q2 FY2026, up 0.6 pp from a year earlier.
  • Accumulated OCI grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -7.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$276.98M-7.0% QoQ
Last fiscal yearDec 2025
-$239.47M+24.4% YoY
Year agoJun 2025
-$258.65M-7.1% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.1%——
1 year+24.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
(239.47M) USD
Year-over-year change
+24.4%

Accumulated OCI vs competitors

How TFX compares with its peers on the latest reported figures

  • Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -7.1% is the 2nd highest of 10, against a peer median of -210.7%.
  • Accumulated OCI amounts to 4.1% of total assets for TFX, versus a peer median of 0.3%.
TFX Competitors
Accumulated OCI for TFX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PTCTPTC Therapeutics, Inc.Jun 2026$6.02M USD-18.2%+29.9%0.2%
TGTXTG Therapeutics, Inc.Sep 2026$0 USD——0.0%
ALKSAlkermes plcSep 2026-$3.29M USD-210.7%—0.1%
KRYSKrystal Biotech, Inc.Jun 2026-$4.34M USD-474.7%—0.3%
PCVXVaxcyte, Inc.Jun 2026-$7.55M USD-299.9%—0.2%
ARWRArrowhead Pharmaceuticals, Inc.Sep 2026-$7.65M USD-218.7%—0.4%
MMSIMerit Medical Systems, Inc.Sep 2026-$10.52M USD-182.8%——
CRSPCRISPR Therapeutics AGSep 2026-$14.08M USD-382.5%—0.6%
STVNStevanato Group S.p.A.Jun 2026-€33.79M EUR-102.6%—1.3%
TFXTeleflex IncorporatedJun 2026-$276.98M USD-7.1%—4.1%
BLCOBausch + Lomb CorporationJun 2026-$1.22B USD-2.3%—8.8%
Peer median (excluding TFX) —-210.7%+29.9%0.3%

Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents445.08M292.03M222.85M290.19M393.26M
Short-term Investments00015.97M0
Net Receivables383.57M408.83M443.47M459.5M345.58M
Inventory477.64M578.51M626.22M600.13M404.4M
Other Current Assets117.28M125.08M107.47M101.88M775.53M
Total Current Assets1.43B1.41B1.41B1.47B1.94B
Property, Plant & Equipment (Net)573.41M578.42M603.43M611.76M590.1M
Goodwill2.5B2.54B2.91B2.63B2.31B
Intangible Assets2.29B2.31B2.5B2.27B1.52B
Long-term Investments011.91M0011.19M
Tax Assets6.82M6.4M6.75M11.37M12.59M
Other Non-current Assets69.1M77.46M98.94M102.62M565.82M
Total Non-current Assets5.44B5.52B6.13B5.63B5.01B
Total Assets6.87B6.93B7.53B7.1B6.95B
Account Payables118.24M126.81M132.25M141.03M130.2M
Short-term Debt110M87.5M87.5M100M100M
Tax Payables83.94M24.74M41.45M41.32M18.79M
Deferred Revenue00000
Other Current Liabilities55.63M63.38M46.55M68.54M388.27M
Total Current Liabilities680.12M581.49M606.75M649.36M762.03M
Long-term Debt1.74B1.62B1.73B1.56B2.54B
Deferred Tax Liabilities370.12M388.89M456.08M391.07M183.75M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities210.6M191.26M189.86M124.32M251.04M
Total Non-current Liabilities2.44B2.32B2.48B2.17B3.06B
Total Liabilities3.12B2.91B3.09B2.82B3.82B
Common Stock47.93M47.96M48.05M48.1M48.2M
Retained Earnings3.52B3.82B4.11B4.12B3.15B
Accumulated OCI(346.96M)(403.52M)(314.41M)(316.67M)(239.47M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.75B4.02B4.44B4.28B3.12B
Total Debt1.97B1.83B1.93B1.76B2.73B
Net Debt1.52B1.54B1.7B1.46B2.33B

Teleflex Incorporated

NYSE:TFX

Intrinsic Alpha fair value

Locked

Current Price

$165.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.